Abstract | OBJECTIVE: METHODS: We searched PubMed up to April 9th, 2012, to identify relevant papers, and 8 published case-control studies including 2165 EC patients and 3141 healthy controls were yielded. Odds ratios ( ORs) with relevant 95% confidence intervals (CIs) were applied to assess the association between XPD Asp312Asn polymorphism and EC susceptibility with the Comprehensive Meta-Analysis software, version 2.2. RESULTS: Overall, the meta-analysis results suggested the XPD Asp312Asn polymorphism to be significantly associated with EC susceptibility [(Asn/Asn+Asp/Asn) vs. Asp/Asp: OR=1.20, 95%CI=1.05-1.36, p=0.01; and Asp/Asn vs. Asp/Asp: OR=1.15, 95%CI=1.01-1.31, p=0.04]. In the subgroup analysis by ethnicity and cancer type, significantly associations were found for Caucasian populations [(Asn/Asn+Asp/Asn) vs. Asp/Asp: OR=1.26, 95%CI=1.08-1.47, p<0.001; Asp/Asn vs. Asp/Asp: OR=1.19, 95%CI=1.02- 1.40, p=0.03] and esophageal squamous cell carcinoma [(Asn/Asn+Asp/Asn) vs. Asp/Asp: OR=1.19, 95%CI=1.01-1.41, p=0.04]. There was no heterogeneity and no publication bias existed. CONCLUSIONS: This meta-analysis shows that the XPD Asp312Asn polymorphism may be a risk factor for developing EC, especially for Caucasian populations and esophageal squamous cell carcinoma.
|
Authors | Xiao-Li Duan, Heng Gong, Xian-Tao Zeng, Xiao-Bing Ni, Yan Yan, Wen Chen, Guo-Lei Liu |
Journal | Asian Pacific journal of cancer prevention : APJCP
(Asian Pac J Cancer Prev)
Vol. 13
Issue 7
Pg. 3299-303
( 2012)
ISSN: 2476-762X [Electronic] Thailand |
PMID | 22994751
(Publication Type: Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Xeroderma Pigmentosum Group D Protein
- ERCC2 protein, human
|
Topics |
- Carcinoma, Squamous Cell
(genetics)
- Case-Control Studies
- Esophageal Neoplasms
(genetics)
- Genetic Predisposition to Disease
- Genotype
- Humans
- Odds Ratio
- Polymorphism, Single Nucleotide
- Risk Factors
- White People
(genetics)
- Xeroderma Pigmentosum Group D Protein
(genetics)
|